SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons sharp rebound is being linked by traders to Morgan Stanley naming it a top pick on AWS growth and AI prospects, as well as AWS making its Trainium chips easier for developers to use. Bulls welcome the move and point to cloud and AI momentum, while skeptics question whether it can hold amid heavy capex and recent volatility.

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.

Disc Medicine Inc

Disc Medicine shares are surging after bitopertin met all primary and secondary endpoints in the Phase 3 APOLLO trial for erythropoietic protoporphyria, strengthening the case for an FDA resubmission, though approval remains ahead and dizziness incidence has drawn some concern. Traders are broadly bullish on the trial result, with discussion also focused on short-covering and whether the rally can hold.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea shares are drawing attention after a sharp selloff and break below technical support, with traders pointing to disclosed insider selling and a DBS downgrade as possible pressures. The community is divided between expecting further declines and viewing the pullback as a buying opportunity, while some also cite weakness in Indonesian markets and broader regional macro concerns.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

A stronger-than-expected third quarter and an upbeat 2027 EBITDA outlook are driving CLFs rally, with bullish traders anticipating short covering. Others warn the outlook depends on steel prices and remain focused on the companys debt, while some see the move as a sell-the-news bounce.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBios FDA expansion of Anktiva plus BCG to papillary-only bladder cancer, alongside positive long-term trial data, is the main focus. The share-price decline despite those developments has prompted debate over profit-taking, broader biotech weakness and options activity, while some traders allege manipulation without substantiation.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras is drawing attention amid a steep post-IPO selloff, with traders citing insider share sales and upcoming lockup releases as added supply pressure alongside concerns about valuation, growth and its OpenAI exposure. Bears warn of further downside, while bulls argue the decline is overdone and are buying the dip; some also attribute weakness to a broader AI and semiconductor-sector retreat.

Sunrun, Inc. engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems. It sells solar service offerings and installs solar energy systems for homeowners. Customers can access its products through three channels: direct-to-consumer, solar partnerships, and strategic partnerships. The company was founded by Edward Harris Fenster, Robert Nat Kreamer, and Lynn Michelle Jurich in January 2007 and is headquartered in San Francisco, CA.

Sunrun Inc

Sunrun is drawing attention amid a persistent selloff and weak solar-sector sentiment, with traders pointing to interest-rate sensitivity, policy and financing concerns, and analyst target cuts. The debate is whether its AI data-center, battery-storage and virtual-power-plant initiativesand perceived high short interestcould offset those pressures; some traders view them as a potential turnaround catalyst, while others remain bearish.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is drawing attention around its MSToronto multiple-sclerosis presentations, especially initial Phase 1 azer-cel findings in progressive MS and additional BRIUMVI data. Traders are hopeful the readouts and coming BRIUMVI milestones could support growth, while others are frustrated by choppy trading; buyout talk remains speculation.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

Goldman Sachs upgrade of CoreWeave to Buy prompted hopes for a rebound after a sharp selloff, but traders remain focused on the companys debt burden, bond-market stress, and ability to finance expansion. Bulls point to AI demand and contracted backlog as support, while bears argue those commitments may not translate into enough cash flow to cover financing needs.

Almonty Industries, Inc. engages in the mining, processing, and shipment of tungsten concentrates. Its projects include Almonty Korea Tungsten, Panasquiera mine, Gentung, Almonty Korea Moly, Los Santos mine, and Valtreixal. The company was founded on September 28, 2009 and is headquartered in Dillon, MT.

Almonty Industries Inc

Almontys investor-day presentation is drawing criticism after the shares fell, with traders saying CEO Lewis Black appeared disengaged and questioning whether the meeting contained undisclosed negatives. Others said they heard no clearly bad news, leaving the selloffs cause uncertain amid ongoing scrutiny of the Sangdong production ramp.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Can THC's Cash Flow Support Its Expanding Capital-Return Strategy?

Tenet Healthcare's stronger cash flow is fueling bigger buybacks, but growth investments and capital needs will test how sustainable its strategy is.

Implied Volatility Surging for Universal Health Services Stock Options

Investors need to pay close attention to UHS stock based on the movements in the options market lately. 

Can Shorter Hospital Stays Help HCA Handle More Patient Demand?

HCA's rising admissions and shorter hospital stays could help it meet growing patient demand while using existing capacity more efficiently.

Can Tenet Healthcare Sustain Growth Despite Lower Surgical Volumes?

THC's revenue growth persists despite softer surgical volumes, driven by higher revenue per case, acuity and favorable service mix.

How Acadia Healthcare Is Turning Capacity Growth Into Cash Flow

ACHC is converting capacity expansion into stronger cash flow as new facilities mature, patient volumes rise and capital spending stays disciplined.

Can Operational Resiliency Protect HCA's Long-Term Profitability?

HCA Healthcare's resiliency program is helping control costs amid payer pressures, potentially supporting long-term profitability and EBITDA growth.

Why Is Universal Health Services (UHS) Up 5.7% Since Last Earnings Report?

Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT SEPTEMBER HEALTHCARE CONFERENCES

UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT SEPTEMBER HEALTHCARE CONFERENCES UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT SEPTEMBER HEALTHCARE CONFERENCES PR Newswire KING OF PRUSSIA, Pa., Aug. 25, 2026 KING OF PRUSSIA, Pa., Aug. 25, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE...

Universal Health Shares Drop 21% YTD: Should You Buy Now?

UHS' 21% YTD slide has cheapened its valuation, but weaker volumes, ACA pressure and lower growth forecasts keep risks elevated.

UHS Adds Talkspace to Accelerate Virtual Behavioral Health Growth

Universal Health's $835M Talkspace acquisition expands virtual behavioral health, adding 6,000 providers and new growth opportunities.

Universal Health Services, Inc. engages in providing hospital and healthcare services. It operates through the following segments: Acute Care Hospital Services, Behavioral Health Care Services, and Other. The Acute Care Hospital Services segment includes hospitals, freestanding emergency departments, and ambulatory centers. The Behavioral Health Care Services segment offers treatment programs for depression, anxiety, psychotic diagnoses, bipolar disorder, post-traumatic stress disorder, and neurorehabilitation. The Other segment consists of centralized services such as information technology, purchasing, reimbursement, accounting and finance, taxation, legal, advertising, and design and construction. The company was founded by Alan B. Miller in 1979 and is headquartered in King of Prussia, PA.

Universal Health Services, Inc. - Ordinary Shares - Class B

TDOC Stock Surges 10% Pre-Market, Analyst Cites ‘Compelling’ Valuation After Talkspace Deal

Equity

Neutral Sentiment

<ul class="summary-bullets"><li>Deutsche Bank upgraded Teladoc to Buy from Hold and set a price target of $11, more than double Monday’s closing price.</li><li>Deutsche Bank noted a “potential exit scenario” for Teledoc Health after Talkspace was acquired by Universal Health.</li><li>UHS’ Talkspace acquisition is “a clear positive for Teladoc,” said BoFA.</li></ul>Teladoc Health (TDOC) drew investor interest on Tuesday, with its shares surging more than 10% in pre-market trading, following a couple of bullish brokerage actions, citing the stock’s “compelling” valuation.If the pre-market levels hold, <a href="https://stocktwits.com/symbol/TDOC">TDOC stock</a> could open at its highest price since Jan. 26, 2026.The company caught brokerages’ attention after its peer <a href="https://stocktwits.com/symbol/TALK">Talkspace (TALK)</a> signed a deal to be acquired by <a href="https://stocktwits.com/symbol/UHS">Universal Health Services (UHS)</a> for $5.25 per share, or about $835 million, on Monday. The transaction is expected to close in the third quarter of 2026.<h2 class="st-heading-2">Analyst Highlights “Potential Exit Scenario” For Teladoc</h2>Deutsche Bank upgraded Teladoc to ‘Buy’ from ‘Hold’ and set a price target of $11, according to&nbsp;The Fly. This represents a 107% upside from the stock’s closing price of $5.3 on Monday.The brokerage said Teladoc’s valuation looks “compelling” at current levels and believes the company has a “deliverable strategy” for BetterHelp, its online therapy platform. Deutsche Bank also noted a “potential exit scenario”, pointing to a comparable transaction that could serve as a roadmap for the company.While BetterHelp has recently faced declining growth, the firm believes Teladoc’s integrated care segment continues to expand, and management has a long-term plan to stabilize and return BetterHelp to growth, the firm added.Meanwhile, BofA raised its price target on Teladoc to $8.25 from $7 and maintained a ‘Buy’ rating. UHS’ Talkspace acquisition is “a clear positive for Teladoc” that provides “further support that the market is undervaluing Teladoc's virtual therapy business as well as the rest of Teladoc,” it said.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits shifted to “bullish” from “bearish” over the past 24 hours.<img src="https://news.stocktwits-cdn.com/TDOC_jpg_10651f7b4a.webp" alt="TDOC.jpg">Chatter was largely bullish, with one user saying the company would be worth over $200 billion.<stembedurl>https://stocktwits.com/trplbiem/message/647086931</stembedurl>Another user said, “Teledoc is better equipped than any of their competitors.”<stembedurl>https://stocktwits.com/Idonno/message/647090994</stembedurl>Year-to-date, the stock has declined around 17%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-inkt-stock-surge-in-pre-market-today/cZdoFYVRIeu">Why Did INKT Stock Surge 70% In Pre-Market Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Teladoc logo is seen on a smartphone screen and in the background. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Teladoc Health drew investor interest following a couple of bullish brokerage actions after peer Talkspace signed an acquisition agreement with Universal Health Services a day earlier.

TDOC Stock Surges 10% Pre-Market: Wall Street Sees ‘Compelling’ Valuation, Retail Traders Shift Tone

ARK Innovation ETF

Talkspace Inc

Teladoc Health Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$182.66
Prev Close	$185.10
Open	$185.29
Dividend Yield	0.37%
50-Day Moving Average	$175.36
Beta	0.54
Avg. Volume	782,981.31
PE Ratio	7.54

52-Week High	$246.33
52-Week Low	$140.08
Market Capitalization	$10.91B
EPS (Annual)	$23.10
Price to Book	1.45
Revenue Per Employee	$171,082.06

Feed

News

Sentiment

Earnings

Fundamentals

Info

UHS Fundamentals